3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Lung Neoplasms
4
Colorectal Neoplasms
4
Stomach Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Neoplasms
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Wilms Tumor
1
Venous Thromboembolism
1
Uveal Melanoma
1
Untreated Human Epidermal Growth Factor Receptor-2(HER2)Positive Early Breast Cancer
1
Smoking Cessation
1
Recurrence
1
Rectal Neoplasms
1
Pulmonary Disease, Chronic Obstructive
1
Neoplastic Cells, Circulating
1
Motor Activity
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Leukemia, Myeloid, Acute
1
Leukemia
1
Hodgkin Disease
1
Hepatic Veno-Occlusive Disease
1
HPV Positive Oropharyngeal Squamous Cell Carcinoma
1
Fibrosis
1
Esophageal Neoplasms
1
Colorectal Neoplasms, Hereditary Nonpolyposis
1
Colonic Neoplasms
1
Cardiovascular Diseases
1
Carcinoma, Hepatocellular
1
Breast Neoplasms
1
Interventions
Endoscopy, Digestive System
3
Endoscopy
3
Radiotherapy
2
Biopsy
2
chlorhexidine gluconate
1
Specimen Handling
1
Risk Assessment
1
Radiation
1
Nivolumab
1
Mass Screening
1
Magnetic Resonance Spectroscopy
1
Immune Checkpoint Inhibitors
1
High-Throughput Screening Assays
1
High-Intensity Interval Training
1
Hematologic Tests
1
Gene Expression Profiling
1
Fluorodeoxyglucose F18
1
Fecal Microbiota Transplantation
1
Endoscopic Ultrasound-Guided Fine Needle Aspiration
1
Endoscopic Mucosal Resection
1
Drug Therapy
1
Cryotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Adenocarcinoma Of Esophagus
×
Hematologic Tests
×
Clear all
NCT02610764
2017-04-13
ESO-CTC
University Hospital Freiburg
Phase NA
Completed
19 enrolled